Cogent Biosciences (COGT) Change in Receivables (2017 - 2020)
Cogent Biosciences (COGT) posted quarterly Change in Receivables of -$2.0 million for Q1 2020, down 637.63% year-over-year from $372000.0 in Q2 2019, and down 278.57% quarter-over-quarter from $1.1 million in Q4 2019.
Powered by 
Analysis
Cogent Biosciences (COGT) Change in Receivables (2017 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has reported Change in Receivables for 4 consecutive years, with -$2.0 million the latest figure, recorded in Q1 2020.
- In Q1 2020, Change in Receivables fell 637.63% year-over-year to -$2.0 million; the TTM figure through Dec 2020 stood at -$2.0 million (down 702.41% YoY), while the FY2020 annual figure was -$2.0 million, down 702.41% from the prior year.
- Change in Receivables slipped to -$2.0 million in Q1 2020 per COGT's latest filing, from $1.1 million in the prior quarter.
- Across five years, Change in Receivables topped out at $1.1 million in Q4 2019 and bottomed at -$2.0 million in Q1 2020.
- Historically, Change in Receivables has averaged -$71384.6 across 4 years, with a median of $217000.0 in 2018.
- Annual changes were most pronounced in 2018 — Change in Receivables soared 1980.49% — and 2020, when it slumped 637.63%.
- Cogent Biosciences' Change in Receivables stood at -$681000.0 in 2017, then surged by 136.56% to $249000.0 in 2018, then surged by 349.8% to $1.1 million in 2019, then slumped by 278.57% to -$2.0 million in 2020.
- Business Quant data shows COGT's Change in Receivables at -$2.0 million in Q1 2020, $1.1 million in Q4 2019, and -$612000.0 in Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Cogent Biosciences | 5.94 Bn | 5.94 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | -2.00 Mn |
| Dec 31, 2019 | 1.12 Mn |
| Sep 30, 2019 | -612,000.00 |
| Jun 30, 2019 | -548,000.00 |
| Mar 31, 2019 | 372,000.00 |
| Dec 31, 2018 | 249,000.00 |
| Sep 30, 2018 | 217,000.00 |
| Jun 30, 2018 | -399,000.00 |
| Mar 31, 2018 | 771,000.00 |
| Dec 31, 2017 | -681,000.00 |
| Sep 30, 2017 | 253,000.00 |
| Jun 30, 2017 | 371,000.00 |
| Mar 31, 2017 | -41,000.00 |